180 related articles for article (PubMed ID: 34793125)
1. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
2. RGD-modified lipid disks as drug carriers for tumor targeted drug delivery.
Gao J; Xie C; Zhang M; Wei X; Yan Z; Ren Y; Ying M; Lu W
Nanoscale; 2016 Apr; 8(13):7209-16. PubMed ID: 26972577
[TBL] [Abstract][Full Text] [Related]
3. Turning Toxicants into Safe Therapeutic Drugs: Cytolytic Peptide-Photosensitizer Assemblies for Optimized In Vivo Delivery of Melittin.
Jia HR; Zhu YX; Xu KF; Wu FG
Adv Healthc Mater; 2018 Aug; 7(16):e1800380. PubMed ID: 29931753
[TBL] [Abstract][Full Text] [Related]
4. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
[TBL] [Abstract][Full Text] [Related]
5. Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo.
Huang C; Jin H; Qian Y; Qi S; Luo H; Luo Q; Zhang Z
ACS Nano; 2013 Jul; 7(7):5791-800. PubMed ID: 23790040
[TBL] [Abstract][Full Text] [Related]
6. Homologous polydopamine ameliorates haemolysis of melittin for enhancing its anticancer efficacy.
Zheng Y; Wei Q; Han X; Tao X; Cao T; Chen T; Cao P; Zhan Q
J Mater Chem B; 2024 Jun; 12(22):5431-5438. PubMed ID: 38726737
[TBL] [Abstract][Full Text] [Related]
7. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
8. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle.
Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547
[TBL] [Abstract][Full Text] [Related]
9. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis.
Li Y; Xu N; Zhu W; Wang L; Liu B; Zhang J; Xie Z; Liu W
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22974-22984. PubMed ID: 29920061
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin.
Jiang SP; He SN; Li YL; Feng DL; Lu XY; Du YZ; Yu HY; Hu FQ; Yuan H
Int J Nanomedicine; 2013; 8():3141-50. PubMed ID: 23990722
[TBL] [Abstract][Full Text] [Related]
12. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
13. Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer.
Zhang T; Bai L; You R; Yang M; Chen Q; Cheng Y; Qian Z; Wang Y; Liu Y
J Mater Chem B; 2024 Jun; 12(22):5465-5478. PubMed ID: 38742364
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery.
Li J; Chen YC; Tseng YC; Mozumdar S; Huang L
J Control Release; 2010 Mar; 142(3):416-21. PubMed ID: 19919845
[TBL] [Abstract][Full Text] [Related]
16. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
17. Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.
Jallouk AP; Palekar RU; Marsh JN; Pan H; Pham CT; Schlesinger PH; Wickline SA
Bioconjug Chem; 2015 Aug; 26(8):1640-50. PubMed ID: 26083278
[TBL] [Abstract][Full Text] [Related]
18. Targeting lipodisks enable selective delivery of anticancer peptides to tumor cells.
Ahlgren S; Reijmar K; Edwards K
Nanomedicine; 2017 Oct; 13(7):2325-2328. PubMed ID: 28712916
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.
Wang Z; Zang A; Wei Y; An L; Hong D; Shi Y; Zhang J; Su S; Fang G
Drug Des Devel Ther; 2020; 14():1095-1105. PubMed ID: 32210538
[TBL] [Abstract][Full Text] [Related]
20. Pre- and Post-Transcriptional Regulation of cFLIP for Effective Cancer Therapy Using pH-Ultrasensitive Nanoparticles.
Phung CD; Tran TH; Choi JY; Jeong JH; Ku SK; Yong CS; Kim JO
ACS Appl Mater Interfaces; 2021 Feb; 13(5):5999-6010. PubMed ID: 33506682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]